Lawrence L Horstman

Title: Innovations by Lawrence L Horstman

Introduction

Lawrence L Horstman is a notable inventor based in Plantation, FL (US). He has made significant contributions to the field of medical technology, particularly in the development of innovative treatments for excessive bleeding. With a total of 2 patents, his work has the potential to impact various medical practices.

Latest Patents

Horstman's latest patents include a composition comprising red cell-derived microparticles and a method of treating excessive bleeding. This composition demonstrates acetylcholine esterase (AchE) activity of less than 350 pmol/min/10 particles/uL. The method involves administering this composition to a subject to effectively treat excessive bleeding. Another patent focuses on the expanded utility of red blood cell membrane-derived microparticles (RMP) as hemostatic agents. These microparticles are safe, economical, and effective in treating a wide range of bleeding conditions. They can be produced from red blood cells using a high-pressure extrusion membrane shear process and can be lyophilized for storage at room temperature. RMP can be administered to original donors or blood type compatible recipients, making them versatile in clinical applications.

Career Highlights

Throughout his career, Horstman has worked with esteemed institutions such as the University of Miami and Rxmp Therapeutics, Inc. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Some of his notable coworkers include Yeon S Ahn and Wenche Jy. Their collaborative efforts have contributed to the advancement of medical technologies and innovations in the field.

Conclusion

Lawrence L Horstman's contributions to medical technology through his patents and collaborations highlight his commitment to improving treatment options for excessive bleeding. His innovative work continues to pave the way for advancements in healthcare.